From your Sanofi-Aventis website for Taxotere studies: “Very obvious adverse effects over all TAXOTERE signs are infections, anemia, neutropenia, febrile neutropenia, thrombocytopenia, hypersensitivity, neuropathy, dyspnea, dysgeusia, constipation, anorexia, fluid retention, nail disorders, asthenia, pain, nausea, diarrhea, nausea, alopecia, mucositis skin side effects, myalgia”Taxotere FDA Warnings
The FDA has issued a few warnings regarding Taxotere considering that the medication had been approved in 1996. These generally include black box warnings and respective security communications and tag improvements highlighting the medication’s potential risks. You can also click at http://www.taxoterehairlawsuit.com/taxotere-lawsuit-lawyers.aspx to get more details about Taxotere lawsuits.
Blackbox Warning added into Taxotere
Black box warnings are the most powerful warnings issued for pharmaceutical medication. The warnings have been placed carefully on a medication’s tag and highlight acute risks linked to the item.
Taxotere’s tag involves a sizable black box warning which lists several risks connected with the chemotherapy medication. A number of those dangers include:
- Increased Probability of death in patients who have abnormal liver functioning
- Increased Probability of death in patients receiving higher doses of Taxotere
- Uncommonly low white blood cell counts
- Acute hypersensitivity responses
- Intense fluid retention
- Permanent baldness
In 2015, the FDA added fresh details regarding permanent alopecia into the Taxotere tag.The bureau said cases of permanent alopecia were reported from post marketing experience and also the advice was added into the side effects section over the Taxotere tag.